| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $707M | — | — | — | — |
| Op. Income | $235M | — | — | — | — |
| Gross Margin | 38.6% | — | — | — | — |
| Net Margin | 19.7% | — | — | — | — |
| EPS (Diluted) | $0.24 | — | — | — | — |
| Free Cash Flow | $207M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $707M |
| Cost of Revenue | $434M |
| GROSS PROFIT | $273M |
| R&D Expenses | $0 |
| Selling & Marketing | $9M |
| General & Administrative | $14M |
| SG&A Expenses | $23M |
| Other Expenses | $14M |
| Operating Expenses | $38M |
| Cost & Expenses | $472M |
| OPERATING INCOME | $235M |
| Interest Income | $0 |
| Interest Expense | $19M |
| Other Income/Expenses | -$35M |
| INCOME BEFORE TAX | $200M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $155M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $139M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $139M |
| D&A | $110M |
| EBIT | $218M |
| EBITDA | $328M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $707M |
| Cost of Revenue | $434M |
| GROSS PROFIT | $273M |
| R&D Expenses | $0 |
| Selling & Marketing | $9M |
| General & Administrative | $14M |
| SG&A Expenses | $23M |
| Other Expenses | $14M |
| Operating Expenses | $38M |
| Cost & Expenses | $472M |
| OPERATING INCOME | $235M |
| Interest Income | $0 |
| Interest Expense | $19M |
| Other Income/Expenses | -$35M |
| INCOME BEFORE TAX | $200M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $155M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $139M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $139M |
| D&A | $110M |
| EBIT | $218M |
| EBITDA | $328M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $139M |
| Depreciation & Amortization | $110M |
| Stock-Based Compensation | $2M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $38M |
| Change in Working Capital | -$9M |
| OPERATING CASH FLOW | $281M |
| Capital Expenditure | -$74M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $5M |
| NET CASH FROM INVESTING | -$69M |
| Net Debt Issuance | -$108M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$17M |
| NET CASH FROM FINANCING | -$125M |
| FREE CASH FLOW | $207M |
| Net Change in Cash | $91M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $314M |
| Short-Term Investments | $1M |
| Net Receivables | $900.0K |
| Inventory | $301M |
| Other Current Assets | $56M |
| TOTAL CURRENT ASSETS | $689M |
| PP&E (Net) | $4.3B |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $14M |
| Tax Assets | $0 |
| Other Non-Current Assets | $402M |
| TOTAL NON-CURRENT ASSETS | $4.7B |
| TOTAL ASSETS | $5.4B |
| Account Payables | $303M |
| Short-Term Debt | $2M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $74M |
| TOTAL CURRENT LIABILITIES | $409M |
| Long-Term Debt | $971M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $327M |
| TOTAL NON-CURRENT LIABILITIES | $1.4B |
| TOTAL LIABILITIES | $1.8B |
| Common Stock | $3.1B |
| Additional Paid-In Capital | $56M |
| Retained Earnings | $466M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$43M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.6B |
| Minority Interest | $16M |
| TOTAL EQUITY | $3.6B |
| TOTAL LIABILITIES & EQUITY | $5.4B |
| Total Debt | $1.1B |
| Net Debt | $777M |
